Immunome to begin human testing of experimental Covid-19 'cocktail' after FDA lifts clinical hold
March 11, 2022 at 09:57 AM EST
Immunome's IMM-BCP-01 antibody cocktail contains three monoclonal antibodies that target Covid-19.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|